Gene Query: CBFB

Dataset Description Geneva Score
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 71.63
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 58.37
Nrf2 regulated genes in A549 cells 54.84
Identification of Nrf2 regulated genes by RNA sequencing 54.84
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 37.97
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 34.79
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 33.37
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 29.74
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 29.74
IL-33 activates tumor stroma to promote intestinal polyposis 27.92
Mechanistic Model-Guided Study of Embryonic Morphogenesis 26.45
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 25.71
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 24.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 24.75
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 24.48
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 24.23
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 23.87
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 22.24
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 22.22
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 22.22
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 22.14
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 21.92
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 21.75
RNA-Seq analysis of breast cancer cells after shikonin treatment 20.6
Gene expression profile of human iPSC-derived nephron progenitor cells 20.51
Uridylation by TUT4 and TUT7 marks mRNA for degradation 20.35
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 20.32
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 20.29
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 20.02
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 19.5
Cleavage Factor Im as a key regulator of 3’ UTR length 19.36
RNAseq analysis of ESRP regulated splicing events in prostate cancer 19.33
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 19.12
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 18.99
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 18.79
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 18.77
CDK12 mediated transcriptional regulation in U2OS cells 18.77
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 18.75
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 18.05
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 18.01
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 17.71
Illumina Total RNA-seq in HeLa 17.68
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 17.51
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 17.34
Co-transcriptional loading of RNA export factors shapes the human transcriptome 17.28
RNAseq of HEK293 cells after Chtop knockdown 17.28
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 17.25
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 17.19
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 17.13
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 17.04
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 17.03
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 17.03
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 16.98
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 16.86
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 16.83
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 16.6
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 16.44
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 16.44
A role for ZNF598 in post-transcriptional gene regulation 16.41
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 16.37
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 15.9
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 15.75
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 15.63
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 15.6
CD73 knockdown effect in pancreatic cancer cell lines 15.34
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 15.25
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 15.15
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 15.03
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 15.0
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 15.0
Effect of mitochondria deficiency on senescence-associated gene expression 14.92
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 14.87
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 14.55
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 14.54
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 14.54
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 14.51
HNRNPL and its RNA Targets in Prostate Cancer 14.51
TGF-β regulation of miRNA expression in pancreatic cancer 14.4
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 14.38
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 14.38
Effect of disulfiram treatment on pediatric high grade glioma 14.37
RIG-I and MDA5 fRIP during KSHV lytic reactivation 14.33
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 14.17
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 14.08
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 14.05
Trans-differentiation of human adult peripheral blood T cells into neurons 13.97
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 13.92
Effect of CHKA knockdown on C4-2 cell transcriptome 13.65
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.56
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.56
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 13.48
Global gene expression profile of dasatinib-resistant RCH-ACV cells 13.36
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 13.32
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 13.21
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 13.15
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 12.84
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 12.81
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 12.67
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 12.67
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 12.66
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 12.53
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 12.41
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.4
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 12.31
Ribosomal footprinting of CN34-Parental and CN34-LM1a 12.2
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 12.15
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 12.15
IMP3 regulated gene expression in breast cancer cells 12.14
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 12.09
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 12.03
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 12.02
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 12.0
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 11.95
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 11.84
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 11.4
Gene expression profiling of human and murine in vitro muscle differentiation 11.27
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 11.26
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.23
RNA-Seq from early time points in the kidney differentiation protocol 11.21
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 11.2
Regulating Interleukin-2 activity with engineered receptor signaling clamps 11.2
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 11.16
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 11.14
MicroRNA-125a-5p overexpression in human macrophages 11.13
Unique features and clinical importance of acute alloreactive immune responses 11.05
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 11.01
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 10.97
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.93
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 10.9
Solid phase chemistry to covalently and reversibly capture thiolated RNA 10.79
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 10.76
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 10.55
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 10.54
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.46
Genome wide expression change by RNF168 knocking down in NEC cells 10.31
SLIGRL-induced gene expression changes in NHEK cells 10.3
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.28
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.27
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 10.19
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.17
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 10.16
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.14
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 10.12
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.08
The cohesin release factor WAPL restricts chromatin loop extension. 10.06
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 10.06
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 10.02
SLAM-seq for K562 endogenous mRNA decay 10.02
Reassessment of Exosome Composition 9.99
Maturation of human iNSCs 9.96
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 9.95
TT-Seq captures the human transient transcriptome 9.93
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 9.91
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.91
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 9.88
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 9.82
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 9.8
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.79
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.74
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.65
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 9.65
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.64
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.64
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.62
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 9.62
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 9.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 9.56
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 9.56
Expression level comparison under dividing and quiescent states in human primary fibroblasts 9.49
Differential Gene Expression between MCF10A and MCF7 cells 9.49
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 9.48
Silencing SPIB in attached and floating state of H1703 lung cancer cells 9.41
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 9.38
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.34
RNA-seq in transgenic cells 9.34
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 9.25
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 9.25
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.24
Active translatome profiling with RiboLace in MCF7 cells 9.21
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 9.2
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.2
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.2
Altering cancer transcriptomes using epigenomic inhibitors 9.2
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 9.14
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 9.13
TGF-β promotes genomic instability after loss of RUNX3 9.11
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 9.1
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.05
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.05
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.97
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.96
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.89
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.87
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.86
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 8.78
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 8.78
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.77
MYC dependent mRNA translation shapes gene expression and cell biology 8.75
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.74
TCF7L1 knockdown in pancreatic cancer 8.73
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 8.72
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.66
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.65
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 8.63
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.63
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.63
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 8.6
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 8.57
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 8.5
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.5
Effect of FGF13 depletion on the H460 cell line 8.47
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 8.43
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 8.42
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 8.37
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 8.34
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.34
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 8.32
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 8.31
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 8.31
Regulation of hypoxia-inducible factor activity by ZMYND8 8.23
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 8.22
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 8.21
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 8.21
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 8.2
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 8.18
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.14
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.05
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.96
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.95
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.92
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.89
FBXW7 modulates stress response by post-translational modification of HSF1 7.89
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 7.88
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 7.87
MCF-7 as a model for functional analysis of breast cancer risk variants 7.86
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 7.82
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 7.78
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.76
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 7.74
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.74
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 7.71
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 7.7
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 7.7
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 7.68
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 7.6
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.6
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.57
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 7.56
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 7.54
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 7.53
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.53
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 7.5
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.48
Transcriptome analysis upon C6orf203 silencing 7.44
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.42
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 7.42
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 7.38
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.38
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.38
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.34
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 7.29
RNA-seq melanoma 7.28
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 7.27
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 7.27
Tracing Enhancer Networks using Epigenetic Traits (TENET) 7.27
A code of mono-phosphorylation modulates the function of RB. 7.21
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.18
RNA sequencing of primary human platelets and in vitro cell lines 7.18
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.15
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.12
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 7.07
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 7.07
RNA sequencing analysis of human embryonic stem cells and axial progenitors 7.02
EP400 is required for Max and MCPyV mediated gene activation 7.01
LIN28A modulates splicing and gene expression programs in breast cancer cells 7.01
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 7.01
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.86
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.85
BET bromodomain inhibition 6.82
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 6.82
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.76
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.76
Transcriptome-wide modulation of splicing by the exon junction complex 6.73
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.68
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.68
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.65
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 6.59
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 6.58
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.53
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.51
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 6.47
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.41
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.41
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.32
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 6.25
RNA seq comparison between scrambled and shGRP78 cells 6.21
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.19
O-glcnAc reprograms cellular energetics 6.03
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 6.02
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 5.98
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 5.98
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.96
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 5.86
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.85
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.75
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.63
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.61
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.59
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.46
Systematic discovery of endogenous human ribonucleoprotein complexes 5.44
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 5.44
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.41
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 5.4
Ro60-knockout cells 5.3
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 5.3
Differential gene expression of human melanoma cells [RNA-seq] 5.3
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.28
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.25
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.22
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.19
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 5.18
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.13
EGR1-controlled transcriptome of T HESCs 5.09
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 5.07
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 5.01
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.0
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.0
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.93
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.89
Identification of the role of polydom in neurofibromas 4.87
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.85
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 4.83
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.82
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 4.79
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.79
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.79
TAF1 is critical for AE driven leukemogenesis 4.77
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.77
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.69
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.64
Zone dependent distinctive gene expression profile of the normal human liver tissue 4.6
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.54
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.51
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.49
Interaction between mitoNEET and NAF-1 in cancer cells 4.49
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 4.44
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.44
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.43
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.41
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 4.4
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 4.4
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 4.38
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.34
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.2
RNA-seq of RKO cells with cTAZ KO or putback 4.17
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.07
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.96
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 3.88
Regionally specified human pluripotent stem cell-derived astrocytes 3.88
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.87
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.82
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.79
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.72
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.69
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.67
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.53
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.52
N6-methyladenine DNA Modification in Glioblastoma 3.46
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.46
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.46
BACH2 in human plasma cell fate decision 3.43
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.41
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.4
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.4
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.33
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.32
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.25
SF3B1 Degron knockdown RNA-seq 3.25
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.07
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.99
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 2.99
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.88
miR-93 Targets in Human Endothelial Cells 2.88
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 2.86
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.82
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.82
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.81
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.77
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.76
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.7
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.7
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.63
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.59
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 2.57
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.55
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.49
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.47
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.46
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.46
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.45
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.4
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.38
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.38
Determination of tRNA aminoacylation levels by high throughput sequencing 2.31
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.27
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 2.25
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.17
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.17
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.16
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.16
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.16
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.14
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.1
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.07
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.05
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.03
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 2.03
HBEC-shp53-PCHD7 2.02
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.98
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.98
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.94
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.92
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.88
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.73
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.73
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.7
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.63
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.62
Clinker: visualizing fusion genes detected in RNA-seq data 1.62
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.61
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.59
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.58
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.56
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.52
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.51
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.51
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.48
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.48
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.47
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.44
Direct Isolation and Characterization of Human Nephron Progenitors. 1.41
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.41
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.4
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.39
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.33
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.32
Loss of CREBBP results in gene expression repression in lymphoma cells 1.31
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.31
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.31
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.31
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.28
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.27
Transcriptional landscape changes during human embryonic stem cell derivation 1.26
mRNA recovered upon RNF219 IP. [RNA-IP] 1.21
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.21
Derivation and differentiation of haploid human embryonic stem cells 1.19
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.14
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.05
siRNA-mediated knockdown 0.99
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.96
6mer seed toxicity in viral microRNAs 0.94
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.93
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.91
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.89
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.8
Identification of renal resident macrophages across species [C1] 0.67
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.62
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.59
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.59
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.58
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.51
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.49
Transcriptional effect of ETV1 knockdown in melanoma cells 0.47
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.44
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.43
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.43
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.43
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.39
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.36
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.34
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.29
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.25
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.23
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.19
Transcription elongation regulates genome 3D structure 0.17
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.17
Genome-wide analysis of the Integrator complex 0.15
Genome-wide analysis of the Integrator complex (HTS) 0.15
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.12
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.1
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.1
High-resolution comparative analysis of great ape genomes 0.07
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation